135 related articles for article (PubMed ID: 23527729)
21. Niflumic acid and cutaneous reactions in children.
Menniti-Ippolito F; Sagliocca L; Da Cas R; Saggiomo G; Di Nardo R; Traversa G
Arch Dis Child; 2001 May; 84(5):430-1. PubMed ID: 11316692
[TBL] [Abstract][Full Text] [Related]
22. Gastroprotective effects of morniflumate, an esterified anti-inflammatory drug.
Schiantarelli P; Cadel S; Folco GC
Arzneimittelforschung; 1984; 34(8):885-90. PubMed ID: 6333880
[TBL] [Abstract][Full Text] [Related]
23. Possible link between history of hypersensitivity to a specific non-steroidal anti-inflammatory drug (NSAID) and positive results following challenge test to alternative NSAIDS.
Trombetta D; Imbesi S; Vita G; Isola S; Minciullo PL; Saija A; Gangemi S
Arzneimittelforschung; 2009; 59(8):410-4. PubMed ID: 19813464
[TBL] [Abstract][Full Text] [Related]
24. [Tolerability of a selective cyclooxygenase-2-inhibitor (rofecoxib) in patients with intolerance reactions to nonsteroidal anti-inflammatory agents].
Zollner TM; Ahlbach S; Kaufmann R; Boehncke WH
Dtsch Med Wochenschr; 2001 Apr; 126(14):386-8. PubMed ID: 11332239
[TBL] [Abstract][Full Text] [Related]
25. [Efficacy and tolerability of morniflumate in acute otitis in infants: results of a randomized study versus placebos].
Portmann M; Portmann D; Rohou S; Pollet M; Colson J; Cuvelier A; Fournier JL; Jeannerot F; Marx J; Menet V
Rev Laryngol Otol Rhinol (Bord); 1990; 111(5):507-10. PubMed ID: 2087618
[TBL] [Abstract][Full Text] [Related]
26. Tolerability of meloxicam in patients with histories of adverse reactions to nonsteroidal anti-inflammatory drugs.
Quaratino D; Romano A; Di Fonso M; Papa G; Perrone MR; D'Ambrosio FP; Venuti A
Ann Allergy Asthma Immunol; 2000 Jun; 84(6):613-7. PubMed ID: 10875490
[TBL] [Abstract][Full Text] [Related]
27. Single NSAID hypersensitivity is associated with atopic status.
Asero R
Eur Ann Allergy Clin Immunol; 2015 Mar; 47(2):48-53. PubMed ID: 25781194
[TBL] [Abstract][Full Text] [Related]
28. Modeling population pharmacokinetics of morniflumate in healthy Korean men: extending pharmacometrics analysis to niflumic acid, its major active metabolite.
Jeong SH; Jang JH; Lee YB
Naunyn Schmiedebergs Arch Pharmacol; 2024 Feb; 397(2):843-856. PubMed ID: 37515737
[TBL] [Abstract][Full Text] [Related]
29. [A new anti-inflammatory--analgesic--antipyretic for the treatment of acute disease of the bronchi ].
Girbino G; Oliani C; Lauriello G; Condoluci M
Riv Eur Sci Med Farmacol; 1990 Dec; 12(6):359-66. PubMed ID: 2132290
[TBL] [Abstract][Full Text] [Related]
30. Celecoxib tolerability in patients with hypersensitivity (mainly cutaneous reactions) to nonsteroidal anti-inflammatory drugs.
Viola M; Quaratino D; Gaeta F; Caringi M; Valluzzi R; Caruso C; Volpetti S; Romano A
Int Arch Allergy Immunol; 2005 Jun; 137(2):145-50. PubMed ID: 15897671
[TBL] [Abstract][Full Text] [Related]
31. Floctafenine: a valid alternative in patients with adverse reactions to nonsteroidal anti-inflammatory drugs.
Giuseppe P; Antonino R; Alessandro DB; Donato Q; Marina DF; Donatella P; Francesca G; Alberto V
Ann Allergy Asthma Immunol; 1997 Jan; 78(1):74-8. PubMed ID: 9012626
[TBL] [Abstract][Full Text] [Related]
32. [Dysmenorrhea in puberty and adolescence].
Sirakov M; Damianov L; Tsankova M; Draganova D
Akush Ginekol (Sofiia); 2000; 39 Suppl 1():9-10. PubMed ID: 10948634
[No Abstract] [Full Text] [Related]
33. Characteristics of subjects experiencing hypersensitivity to non-steroidal anti-inflammatory drugs: patterns of response.
Doña I; Blanca-López N; Cornejo-García JA; Torres MJ; Laguna JJ; Fernández J; Rosado A; Rondón C; Campo P; Agúndez JA; Blanca M; Canto G
Clin Exp Allergy; 2011 Jan; 41(1):86-95. PubMed ID: 21155908
[TBL] [Abstract][Full Text] [Related]
34. [Side effects of fenamates].
Strauss J; Escousse A; Klepping CL
Therapie; 1976; 31(3):325-42. PubMed ID: 136765
[No Abstract] [Full Text] [Related]
35. [Intolerance reactions to non-steroidal anti-inflammatory agents (NSA) in adolescents].
Bahemann-Hoffmeister A; Debelić M
Monatsschr Kinderheilkd; 1986 Aug; 134(8):522-6. PubMed ID: 3773919
[TBL] [Abstract][Full Text] [Related]
36. Safety of celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and other non-steroidal anti-inflammatory drugs.
Liccardi G; Cazzola M; De Giglio C; Manfredi D; Piscitelli E; D'Amato M; D'Amato G
J Investig Allergol Clin Immunol; 2005; 15(4):249-53. PubMed ID: 16433205
[TBL] [Abstract][Full Text] [Related]
37. The solid state of anti-inflammatory morniflumate diniflumate: A cocrystalline salt.
Barrio M; Ceolin R; Robert B; Allouchi H; Teulon JM; Guéchot C; Tamarit JL; Rietveld IB
Int J Pharm; 2021 Dec; 610():121224. PubMed ID: 34710544
[TBL] [Abstract][Full Text] [Related]
38. Oral drug challenges in non-steroidal anti-inflammatory drug-induced urticaria, angioedema and anaphylaxis.
Chaudhry T; Hissaria P; Wiese M; Heddle R; Kette F; Smith WB
Intern Med J; 2012 Jun; 42(6):665-71. PubMed ID: 21981353
[TBL] [Abstract][Full Text] [Related]
39. Parecoxib tolerability in patients with hypersensitivity to nonsteroidal anti-inflammatory drugs.
Viola M; Quaratino D; Volpetti S; Gaeta F; Romano A
J Allergy Clin Immunol; 2006 May; 117(5):1189-91. PubMed ID: 16675352
[No Abstract] [Full Text] [Related]
40. [Determination of the concentrations of niflumic acid in the plasma and synovial tissue following repeated administration of capsules].
Dorfmann H; Gendron A; Duchenne P
Rev Rhum Mal Osteoartic; 1987 Apr; 54(4):339-41. PubMed ID: 3602910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
